KB

Katie Bodner Spielberg

Principal at 5AM Ventures

Boston, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Education

Lists including Katie

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

5V
5AM Ventures

2020

  • Principal

    2024

  • Senior Associate

    2023 - 2024

  • Associate

    2022 - 2023

  • Analyst

    2021 - 2021

  • Fellow

    2020 - 2020

Lifordi Immunotherapeutics

2023

  • Board Observer

    2023

GA
GlycoEra AG

2021

  • Board Observer

    2021

SU
Stanford University

2015 - 2020

  • Postdoctoral Research Fellow

    2020 - 2020

  • Ph.D. Candidate

    2015 - 2020

    * Funded by the Hertz-Draper Fellowship and the Stanford SGF and EDGE-STEM Fellowships * Thesis: "An Engineering Approach to Uncover Interactions Between Bacteriophages, Bacteria and Mammalian Cells" * Three first author publications in Cell Systems, STAR Protocols and Trends in Microbiology (doi.org/10.1016/j.cels.2020.02.006, doi.org/10.1016/j.xpro.2020.100084,https://doi.org/10.1016/j.tim.2020.10.014).

RW
Ron Weiss Lab at MIT

2012 - 2015

  • Research Assistant

    2012 - 2015

    • Co-authored two publications (Nature Chemical Biology and Expert Review of Vaccines doi.org/10.1038/s41589-018-0146-9 and doi.org/10.1586/14760584.2015.997714) and a patent: U.S. Patent Application No. 15/509,258 (2017). • Earned a Gold Medal at the iGEM (International Genetically Engineered Machines) America’s East Regional Competition.

G
Genentech

2014 - 2014

  • Intern, Late Stage Cell Culture

    2014 - 2014

    • Engineered E. coli cell lines to reduce acetate accumulation in recombinant protein production during fed-batch fermentation and characterized growth in 10-L bioreactors